Kindred Biosciences reported $19.87M in Debt for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Adma Biologics ADMA:US $ 94.36M 0.49M
Bayer BAYN:GR € 41766M 1394M
Biocryst Pharmaceuticals BCRX:US $ 304.16M 10.51M
Dynavax Technologies DVAX:US $ 220.22M 0.26M
Eli Lilly And LLY:US $ 17085.4M 570.3M
Idexx Laboratories IDXX:US $ 853.02M 52.05M
JAZZ PHA JAZZ:US $ 6285.05M 459.25M
Kindred Biosciences KIN:US $ 19.87M 0.13M
Minerva Neurosciences NERV:US $ 0M 0M
Novavax NVAX:US $ 427.09M 3.23M
Phibro Animal Health PAHC:US $ 405.26M 13.18M
Zoetis ZTS:US $ 6592M 604M